Wall Street Journal report links Zoetis' arthritis shots for pets, Librela and Solensia, to thousands of side effects, causing stock fall and regulatory reviews.
Zoetis, a pharmaceutical company, saw its stock fall after a Wall Street Journal report suggested its arthritis shots for dogs and cats, Librela and Solensia, may have sickened pets. The report noted thousands of reports of side effects from the drugs, leading health regulators in the U.S. and Europe to conduct reviews. Zoetis maintains that the drugs are safe, with adverse events accounting for less than 1% of the 18 million combined shots administered.
April 12, 2024
15 Articles